"10.1371_journal.pone.0129022","plos one","2015-06-24T00:00:00Z","Dionysios Neofytos; Radha Railkar; Kathleen M Mullane; David N Fredricks; Bruno Granwehr; Kieren A Marr; Nikolaos G Almyroudis; Dimitrios P Kontoyiannis; Johan Maertens; Rebecca Fox; Cameron Douglas; Robert Iannone; Eunkyung Kauh; Norah Shire","Department of Medicine, Johns Hopkins University, Baltimore, MD, United States of America; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, United States of America; Clinical Research, Merck & Co., Inc., Kenilworth, NJ, United States of America; Department of Medicine, University of Chicago, Chicago, IL, United States of America; Division of Allergy and Infectious Diseases, Fred Hutchinson Center, Seattle, WA, United States of America; Division of Infectious Diseases, University of Texas M.D. Anderson Cancer Center, Houston, TX, United States of America; Roswell Park Cancer Institute, State University of New York, Buffalo, NY, United States of America; Department of Haematology, University Hospital Gasthuisberg, Leuven, Belgium","Conceived and designed the experiments: RR DNF KAM RF JM RI EK NS. Performed the experiments: KMM BG RF NS. Analyzed the data: RR DN DNF BG KAM NGA DPK NS. Contributed reagents/materials/analysis tools: RR DN CD NS. Wrote the paper: DN RR KMM DNF BG KAM NGA DPK JM RF CD RI EK NS.","R. Railkar, R. Fox, C. Douglas, R. Iannone, E. Kauh, and N. Shire are current or former employees of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, which provided funding towards this study. D. Neofytos, D. Fredricks, B. Granwehr and N. Almyroudis report grant from Merck & Co., Inc. K. Mullane reports grant from Merck & Co., Inc., outside the submitted work. K. Marr reports grant from Astellas, Merck & Co., Inc., and Pfizer, and received personal fees from Astellas, Merck, and Pfizer, outside the submitted work. K. Marr reports a US patent: Lateral Flow Device for Diagnosing Microbial Infections, US2013/0017561. D. Neofytos reports grants from Pfizer and personal fees from Roche and Astellas, outside the submitted work. D. Kontoyiannis reports grants from Merck & Co., Inc. and Pfizer; he received personal fees from Pfizer, Gilead, and Schering-Plough, outside the submitted work. J. Maertens reports no conflict of interest. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2015","06","Dionysios Neofytos","DN",14,TRUE,8,4,8,14,TRUE,TRUE,FALSE,0,NA,FALSE
